Sponsor intelligence · OTHER
Clinical trials sponsored by
Beijing Anzhen Hospital.
Real, source-linked trial activity for Beijing Anzhen Hospital: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Nov 3, 2026. Source-linked, daily-refreshed.
NA 1PHASE2/PHASE3 1
Newest Beijing Anzhen Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 8d ago | Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter A | NA | NOT_YET_RECRUITING | ↗ |
| 50d ago | Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection | Ph 2/Ph 3 | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Beijing Anzhen Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.